Trisomy 21 as a Sole Acquired Abnormality in an Adult Omani Patient with CD7- and CD9-Positive Acute Myeloid Leukemia

Achandira M. Udayakumar, Anil V. Pathare, S. Muralitharan, Asem A. Alghzaly, Salam Alkindi, J. A. Raeburn

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We describe a case of acute myeloid leukemia (AML) in which trisomy 21 was the sole acquired cytogenetic abnormality. The immunophenotype showed positivity for CD7 and CD9 along with CD13, CD33, and CD34. The chromosomal analysis of bone marrow showed 47,XY +21 in all the metaphases analyzed. The constitutional karyotype was normal. The patient was an adult and did not have any features of Down's syndrome. The bone marrow morphology was AML-M2 as per the French-American-British (FAB) criteria. A final diagnosis of CD7- and CD9-positive AML-M2 was established with trisomy 21 as a sole cytogenetic abnormality. The patient responded remarkably well to chemotherapy and achieved complete clinical remission. This is the first case of CD7- and CD9-positive AML with trisomy 21 as a sole abnormality. A putative role for the co-expression of abnormal lymphoid markers in achieving quick remission is discussed.

Original languageEnglish
Pages (from-to)797-802
Number of pages6
JournalArchives of Medical Research
Volume38
Issue number7
DOIs
Publication statusPublished - Oct 2007

Keywords

  • Acute myeloid leukemia
  • Cytogenetics
  • Prognosis
  • Trisomy 21

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Trisomy 21 as a Sole Acquired Abnormality in an Adult Omani Patient with CD7- and CD9-Positive Acute Myeloid Leukemia'. Together they form a unique fingerprint.

  • Cite this